Cancer treatment has improved, but resistance to therapy remains a critical challenge. Some tumors do not respond to standard treatments, while others initially respond but later develop resistance. The reasons for this resistance are complex and involve genetic, epigenetic, and microenvironmental factors. Deciphering these mechanisms could lead to the development of more robust treatment strategies.
